Global Health Limited will host a one-to-one investor meeting with USS Investment Management Ltd on September 23, 2026. The session is scheduled to take place in Gurugram.

The company disclosed the schedule pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The engagement is classified as an institutional investor meeting.

Rahul Ranjan, Company Secretary and Compliance Officer, confirmed the details in a filing dated September 17, 2026. The company stated that no unpublished price-sensitive information is proposed to be shared during the interaction.

The meeting schedule remains subject to change due to unforeseen circumstances involving the analysts, investors, or the company.

Global Health disclosed the voting results of its 22nd Annual General Meeting held on September 16, 2026. Shareholders approved all four ordinary resolutions with overwhelming support, including the declaration of a final dividend of ₹0.50 per equity share for FY26.

The meeting, conducted via video conferencing, also saw the re-election of Group CEO Pankaj Sahni as a director. The audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026, were adopted without any qualifications from the auditors.

Voting Results

The consolidated scrutinizer’s report, issued by M/s Mukesh Agarwal & Co., detailed the vote counts for each resolution. Remote e-voting was conducted from September 12, 2026, to September 15, 2026, while e-voting during the AGM remained open for 15 minutes after the conclusion of the meeting.

Key Resolutions Passed

Shareholders approved the following ordinary resolutions:

• Adoption of audited standalone and consolidated financial statements for FY26.
• Declaration of final dividend of ₹0.50 per equity share.
• Re-election of Mr. Pankaj Sahni (DIN: 07132999) as a director upon retirement by rotation.
• Approval of remuneration for M/s Ramanath Iyer & Co. as cost auditors for FY27.

Management Commentary

Dr. Naresh Trehan, Chairman & Managing Director, opened the meeting by thanking shareholders for their continued support. He highlighted the company’s commitment to excellence in healthcare delivery and patient care.

Mr. Pankaj Sahni, Group CEO & Director, updated members on the key financial and operational achievements for FY26. He acknowledged the guidance provided by the Board of Directors and the support from all stakeholders.

Meeting Details

The quorum was present at the start of the meeting. As on the cut-off date of September 10, 2026, there were 138,076 shareholders entitled to vote. M/s Mukesh Agarwal & Co., Company Secretaries, served as the scrutinizer for the voting process. The results were unblocked on September 16, 2026, in the presence of two independent witnesses.